Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials (Breast Cancer Research and Treatment, (2017), 163, 2, (295-302), 10.1007/s10549-017-4191-y)

E R R A T U M

Erratum to: Tumor-infiltrating lymphocytes and molecular

response after neoadjuvant therapy for HR+/HER22 breast

cancer: results from two prospective trials

M. V. Dieci

_{A. Frassoldati}

_{D. Generali}

_{G. Bisagni}

_{F. Piacentini}

L. Cavanna

_{K. Cagossi}

_{F. Puglisi}

_{A. Michelotti}

_{R. Berardi}

G. Banna

_{A. Goubar}

_{G. Ficarra}

_{G. Griguolo}

_{Pierfranco Conte}

V. Guarneri

Published online: 3 April 2017

Ó Springer Science+Business Media New York 2017

Erratum to: Breast Cancer Res Treat

DOI 10.1007/s10549-017-4191-y

In the original publication of the article, the eighth and

ninth co-author’s affiliations were published incorrectly.

The correct affiliations of the co-authors are given in this

erratum.

In Abstract, the sentence that reads as, ‘‘In this

cohort,... in the high vs low StrTIL group (64% vs 10%,

p = 0.003).’’ should read as ‘‘In this cohort,... in the low

vs high StrTIL group (64% vs 10%, p = 0.003).’’

The online version of the original article can be found under doi:10.1007/s10549-017-4191-y.

& Pierfranco Conte pierfranco.conte@unipd.it

1 _{Department of Surgery, Oncology and Gastroenterology,}

University of Padova, via Giustiniani 2, 35128 Padua, Italy

2 _{Division of Medical Oncology 2, Istituto Oncologico Veneto}

IRCCS, via Gattamelata 64, 35128 Padua, Italy

3 _{Division of Clinical Oncology, S. Anna University Hospital,}

via Moro 8, 44100 Cona, Ferrara, Italy

4 _{Breast UnitASST Cremona, viale Concordia 1,}

26100 Cremona, Italy

5 _{Department of Medical, Surgery & Health Sciences,}

University of Trieste, Piazza Ospitale 1, 34129 Trieste, Italy

6 _{Division of Medical Oncology, Azienda Ospedaliera ASMN,}

IRCSS, Viale Umberto I 50, 42123 Reggio Emilia, Italy

7 _{Department of Medical and Surgical Sciences of Mother,}

Child and Adult, University of Modena and Reggio Emilia, Modena, Italy

8 _{Division of Medical Oncology, Modena University Hospital,}

via del Pozzo 71, 41124 Modena, Italy

9 _{Division of Oncology, ‘‘Guglielmo da Saliceto’’ Hospital, via}

Taverna 49, 29121 Piacenza, Italy

10 _{Division of Medical Oncology, ‘‘B.Ramazzini’’ Hospital, Via}

Molinari 2, 41012 Carpi, Italy

11 _{Department of Medical and Biological Sciences, University}

of Udine, Udine, Italy

12 _{Department of Oncology, University Hospital of Udine,}

Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy

13 _{UO Oncologia Medica I, Azienda Ospedaliera Universitaria}

Pisana, Santa Chiara Hospital, via Roma 67, 56126 Pisa, Italy

14 _{Division of Medical Oncology, Universita` Politecnica delle}

Marche, Ospedali Riuniti Umberto I, via Conca 71, 60126 Ancona, Italy

15 _{Division of Medical Oncology, Cannizzaro Hospital, via}

Messina 829, 95126 Catania, Italy

16 _{ICR Clinical Trials and Statistics Unit, 15 Cotswold Road,}

Sutton SM2 5NG, UK

17 _{Division of Pathology, Modena University Hospital, via del}

Pozzo 71, 41124 Modena, Italy

123

Breast Cancer Res Treat (2017) 163:637 DOI 10.1007/s10549-017-4219-3